PHILADELPHIA, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NRG ONCOLOGY FOUNDATION INC, founded in 2013, is a mid-sized nonprofit in the Medical Research sector that reported $35.5M in total revenue in fiscal year 2024.
NRG ONCOLOGY SEEKS TO IMPROVE THE LIVES OF PATIENTS WITH CANCER BY CONDUCTING PRACTICE-CHANGING MULTI-INSTITUTIONAL CLINICAL AND TRANSLATIONAL RESEARCH WITH EMPHASES ON SEX-SPECIFIC MALIGNANCIES INCLUDING GYNECOLOGIC, BREAST, AND PROSTATE CANCERS AND ON LOCALIZED OR LOCALLY ADVANCED CANCERS OF ALL TYPES.
CONDUCTING PRACTICE-CHANGING MULTI-INSTITUTIONAL CLINICAL AND TRANSLATIONAL RESEARCH WITH EMPHASES ON SEX SPECIFIC MALIGNANCIES INCLUDING GYNECOLOGIC, BREAST, AND PROSTATE CANCERS AND ON LOCALIZED OR...
CONDUCTING PRACTICE-CHANGING MULTI-INSTITUTIONAL CLINICAL AND TRANSLATIONAL RESEARCH WITH EMPHASES ON SEX SPECIFIC MALIGNANCIES INCLUDING GYNECOLOGIC, BREAST, AND PROSTATE CANCERS AND ON LOCALIZED OR LOCALLY ADVANCED CANCERS OF ALL TYPES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $35,451,240 | $33,930,638 | +0.0% |
| Expenses | $35,536,029 | $34,275,864 | +0.0% |
| Net Income | $-84,789 | $-345,226 | -0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| QUYNH-THU LE MD | CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| NORMAN WOLMARK MD | TREASURER | 4.00 |
Officer
Director
|
$0 | $0 | $200,003 |
| CAROL AGHAJANIAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID MILLER MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DEBORAH WATKINS BRUNER PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HARRY BEAR MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MITCHELL MACHTAY MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT MANNEL MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THOMAS JULIAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $114,999 |
| PAUL DISILVESTRO MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PRIYA RASTOGI MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $60,000 |
| KRISTIN HIGGINS MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES DIGNAM | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TAMBRE LEIGHN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MINESH MEHTA MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TASHANNA MEYERS MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LISA KACHNIC MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHARON HARTSON STINE | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$0 | $27,768 | $120,329 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $35,451,240 | $35,536,029 | $12,567,650 | $-84,789 |
| 2024 | No data | No data | No data | No data |
| 2023 | $32,205,558 | $32,455,011 | $10,141,268 | $-249,453 |
| 2022 | $28,950,325 | $28,391,644 | $11,235,885 | $558,681 |
| 2021 | $27,206,954 | $27,063,744 | $13,392,636 | $143,210 |
| 2020 | $25,991,942 | $25,756,639 | $15,261,445 | $235,303 |
| 2019 | $26,594,144 | $26,331,993 | $9,675,570 | $262,151 |
| 2018 | $24,876,236 | $24,735,777 | $7,391,329 | $140,459 |
Compare NRG ONCOLOGY FOUNDATION INC with other nonprofits in Pennsylvania and across the country.